Terrorists who oppose such rights might deem the Olympics as a symbol for such ideals and view it as the

Terrorists who oppose such rights might deem the Olympics as a symbol for such ideals and view it as the perfect opportunity to strike a blow for democracy and peace. Security will be heightened to unprecedented levels, but it has become increasingly difficult to prevent such tragedies.Beijing will be another step on the downward path of popularity for the Olympics in America.The winter Olympics in Turin, Italy two years ago saw the lowest television ratings in decades. It may be due to a lack of identity for the Americans, but the issue remains that the summer Olympics in Beijing will mark a milestone for viewer apathy. The issues the organizing committee has faced in completing venues has put a pinch on the aestheticism of the events.The Chinese government has run into a brick wall of recent bad press from Tibet protests and bans of live broadcasts from various event locations. There have even been senators and members of the American Congress calling for a boycott of the opening ceremonies.The Olympics are a significant part of history, providing memories, icons of past epochs, and a means for propagating peace and harmony in a conflicted world.Unfortunately, in a world with few mysteries left between nations, the wealth and star-appeal of professional sports, and battles between ideologies, the Olympics have become obsolete. I am in no way happy to say it, but the 2008 Summer Olympics in Beijing will prove to be another downturn in the popularity of a bygone era..

NEW YORK–(Business Wire)–Reportlinker announces that a new market research report is available in itscatalogue. Scope* What are the current definitions, pathophysiological stages and theclassification of renal anemia? * What are the currently available diagnostic methods, the issues and the unmetneeds in diagnosis and early detection of renal anemia? * What is the current state of pharmacological management, available treatmentapproaches in renal anemia, unmet needs and future trends? * What are the current issues and the commercial landscape of renal anemiamarketplace?HighlightsIn Europe, biogeneric epoetins were expected to address the cost issue, however,so far they have not been particularly well received. This seems to be mostlydue to physician conservatism and the fear of poor generic drug quality withattendant higher risk of side effects. Only Germany has displayed any degree ofenthusiasm for biogenerics.

A number of large clinical trials, such as CHOIR and CREATE, have demonstratedsome controversial results with regards to the relative inefficiency of higherhemoglobin targets. This has encouraged healthcare providers to be conservativein the choice of epoetin therapy creating an additional barrier to epoetinrevenue growth. New epoetin drug therapies predominantly address the length of drug action,allowing for less frequent administration, but unfortunately they provideneither substantial superiority nor significant reduction of costs. In addition,a very small upcoming pipeline does not yet promise any advancement in the areaof superiority or reduction of cost.